Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Kohsaka

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Future Oncology (London, England)|November 9, 2018
Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencingShinji Kohsaka, Mark Petronczki, Flavio Solca, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2026
Real-world clinical characteristics and outcomes in patients with HER2-mutant non-small cell lung cancer (NSCLC) who received second-line treatment: A nationwide database analysis in JapanYuji Uehara, Masachika Ikegami, Shinji Kohsaka, et al.
Cancer Medicine|June 26, 2024
Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in JapanEiji Nakata, Tatsunori Osone, Toru Ogawa, et al.
Oncogene|March 19, 2022
Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor modelHiroshi Ikeuchi, Takeshi Hirose, Masachika Ikegami, et al.
Cancer Research Communications|September 19, 2025
Functional Analysis of Rare RAS Variants of Unknown SignificanceSoohwan Park, Masachika Ikegami, Rina Kitada, et al.
Cancer Letters|December 19, 2012
Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastomaShinji Kohsaka, Kenta Takahashi, Lei Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 4, 2021
Extensive functional evaluation of exon 20 insertion mutations of EGFRTakeshi Hirose, Masachika Ikegami, Makoto Endo, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2021
Programmed death-ligand 1 expression and its associations with clinicopathological features, prognosis, and driver oncogene alterations in surgically resected lung adenocarcinomaKazuya Takamochi, Kieko Hara, Takuo Hayashi, et al.
Biochemical and Biophysical Research Communications|June 28, 2011
A population of BJ fibroblasts escaped from Ras-induced senescence susceptible to transformationShinji Kohsaka, Ken Sasai, Kenta Takahashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2018
High-Throughput Functional Evaluation of Variants of Unknown Significance in <i>ERBB2</i>Masaaki Nagano, Shinji Kohsaka, Toshihide Ueno, et al.
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Future Oncology (London, England)|November 9, 2018
Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencingShinji Kohsaka, Mark Petronczki, Flavio Solca, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2026
Real-world clinical characteristics and outcomes in patients with HER2-mutant non-small cell lung cancer (NSCLC) who received second-line treatment: A nationwide database analysis in JapanYuji Uehara, Masachika Ikegami, Shinji Kohsaka, et al.
Cancer Medicine|June 26, 2024
Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in JapanEiji Nakata, Tatsunori Osone, Toru Ogawa, et al.
Oncogene|March 19, 2022
Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor modelHiroshi Ikeuchi, Takeshi Hirose, Masachika Ikegami, et al.
Cancer Research Communications|September 19, 2025
Functional Analysis of Rare RAS Variants of Unknown SignificanceSoohwan Park, Masachika Ikegami, Rina Kitada, et al.
Cancer Letters|December 19, 2012
Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastomaShinji Kohsaka, Kenta Takahashi, Lei Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 4, 2021
Extensive functional evaluation of exon 20 insertion mutations of EGFRTakeshi Hirose, Masachika Ikegami, Makoto Endo, et al.
Lung Cancer (Amsterdam, Netherlands)|October 2, 2021
Programmed death-ligand 1 expression and its associations with clinicopathological features, prognosis, and driver oncogene alterations in surgically resected lung adenocarcinomaKazuya Takamochi, Kieko Hara, Takuo Hayashi, et al.
Biochemical and Biophysical Research Communications|June 28, 2011
A population of BJ fibroblasts escaped from Ras-induced senescence susceptible to transformationShinji Kohsaka, Ken Sasai, Kenta Takahashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2018
High-Throughput Functional Evaluation of Variants of Unknown Significance in <i>ERBB2</i>Masaaki Nagano, Shinji Kohsaka, Toshihide Ueno, et al.
Pageof 13